International Clinical Trial: The 50% and 95% effective dose of remimazolam combined with sufentanil for induction of general anaesthesia in underweight patients

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121553) titled 'The 50% and 95% effective dose of remimazolam combined with sufentanil for induction of general anaesthesia in underweight patients' on April 1.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Affiliated Hospital of North Sichuan Medical College

Condition: Underweight patients

Intervention: Underweight group:Patients were first administered 0.4 µg/kg of sufentanil. The study was conducted using the Dixon modified sequential method. The initial dose of remimazolam was 0.2 mg/kg, with a dose gradient of 0.02 mg/kg. Except for the first patient, the remimazolam dos...